Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (96)	7/11/2002 12:06:50 PM
From: Hank	Respond to of 684

"But then you pulled the really good one..... paraphrased..... "if big pharma can't succeed, why should a little biotech"." That's right. A biotech with a limited portfolio of targets and an equally limited pipeline has a very limited chance of succeeding. It's just as simple as that. If you don't agree, then buy all the VPHM stock you can get your hands on. It doesn't matter to me. "I trained in pharma. Big, slow behemoths with lazy people." I trained in academia and then went to big pharma. By this statement, is it reasonable to infer that you are lazy? You certainly seem to be since you expect me to lay out in detail why YOU shouldn't invest in VPHM. I have no interest in investing in VPHM- ever- for the reasons I have mentioned. If I am not up to speed on all the details I apologize. However, I do have a little more than a casual knowledge of the area and I still stand by by original prediction that VPHM is "dead meat" based on probability. That's not to say they have a 0% chance of surviving. Just less than 10% IMHO. If you feel so strongly about VPHM, then instead of heckling me why not tell me why you think their development candidates will succeed instead of quoting me how much cash they have? Nobody said they'd go broke tomorrow.